Patient Investors: Why These Stocks Could Return Multiples Over a Decade

Given their high-growth prospects and solid underlying businesses, I expect these three TSX stocks to deliver multi-fold returns over the next 10 years.

Key Points
  • Savaria, Celestica, and WELL Health Technologies are positioned to deliver multi-fold returns over the next decade through exposure to long-term growth trends, including aging populations, AI infrastructure expansion, and healthcare digitization.
  • All three companies currently trade at attractive valuations following recent market pullbacks, offering patient investors compelling entry points to capitalize on their strong fundamentals and growth initiatives.

Long-term investing involves buying and holding stocks for more than three years, allowing investors to ride out short-term volatility while reaping the benefits of compounding. It is also less time-consuming, as it eliminates the need for constant market monitoring. With this in mind, here are three top TSX stocks that can generate multi-fold returns over the next decade.

a person watches stock market trades

Source: Getty Images

Savaria

Savaria (TSX: SIS) designs, manufactures, and markets accessibility solutions worldwide through its direct sales offices and a global sales network of dealers. The aging population and rising income levels have increased the demand for accessibility solutions, thereby creating a long-term growth potential for the company. Furthermore, its “Savaria One” initiative has led to structural improvements, enhanced operational efficiencies, and generated cost savings through streamlined procurement processes. It is also adopting strategies to optimize its North American manufacturing footprint.

Additionally, Savaria has initiated planning for the second stage of “Savaria One,” an initiative that will outline the company’s strategy for the next three years. Along with the expanding addressable market, these growth initiatives could boost its financials in the coming years. Moreover, the company also pays a monthly dividend, with a forward yield of 2.59%, and currently trades at an attractive NTM (next-12-month) price-to-earnings multiple of 17.2, making it an attractive buy.

Celestica

Another TSX stock that I believe would be an excellent long-term investment is Celestica (TSX: CLS), which is benefiting from the expansion of cloud infrastructure and artificial intelligence (AI). The increased usage of AI across businesses has led hyperscalers to expand their AI-ready data centre infrastructure, thereby driving the demand for Celestica’s networking switches and storage controllers. Meanwhile, the company is also developing and launching innovative products to meet the growing needs of its customers.

Furthermore, the rising geopolitical tensions have increased defence budgets, which could benefit its ATS (Advanced Technology Solutions) segment that serves aerospace and defence businesses. Therefore, the company’s long-term growth prospects look healthy. Meanwhile, amid the recent pullback, Celestica’s stock price has fallen over 11% compared to its 52-week high. Also, its NTM price-to-sales multiple stands at 1.8, which looks reasonable, given its higher growth prospects.

WELL Health Technologies

My final pick is WELL Health Technologies (TSX: WELL), which has been under pressure over the last few months, having lost over 35% of its stock value from its 52-week high. The selloff has dragged its valuation down to attractive levels, with its NTM price-to-sales and NTM price-to-earnings multiples of 0.8 and 11.3, respectively.

Furthermore, the digitization of clinical procedures and the growing adoption of virtual healthcare services have expanded the addressable market for WELL Health. The company continues to launch new products and adopt AI-powered solutions to expand its customer base and drive financial performance. The company is also focusing on inorganic growth and has acquired 14 assets as of August 14. Additionally, it has signed 15 letters of intent, which can contribute $134 million to its annualized revenue.

Amid these growth initiatives, WELL Health’s management projects its 2025 topline to grow between 52% and 58%. Its adjusted earnings before interest, taxes, depreciation, and amortization could come in at $190-$210 million, representing a substantial improvement from $46.7 million in 2024.

Fool contributor Rajiv Nanjapla has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

More on Investing

data center server racks glow with light
Energy Stocks

Hammond Power Stock: A Different Way to Invest in the Electricity Buildout

New power demand can mean more work for transformer makers. Hammond’s order book shows the opportunity, and its share price…

Read more »

Woman in private jet airplane
Investing

Air Canada Stock Slides on Fuel Costs: Is the Dip a Buying Opportunity?

Air Canada (TSX:AC) stock might be a promising dip-buy as jet fuel headwinds weigh things down.

Read more »

AI concept person in profile
Tech Stocks

Shopify vs. CGI: Which Canadian Tech Stock Would I Add to a Retirement Portfolio?

Shopify’s growth is hard to ignore. I’d add CGI to a retirement portfolio first because I can put a more…

Read more »

stocks climbing green bull market
Dividend Stocks

In a Few Years, You’ll Probably Regret Not Owning TMX Stock

TMX Group is a quality business, demonstrating growth potential from multiple sources. It's a top candidate for long-term holding.

Read more »

A family watches tv using Roku at home.
Dividend Stocks

Forget Telus Stock: A Dividend Giant I’d Buy Immediately Instead

Telus cut its dividend, and its cash flow is falling. Rogers just posted record free cash flow and held its…

Read more »

happy woman throws cash
Dividend Stocks

1 Way to Use a TFSA to Earn $250 in Monthly Income

Uncover the potential of a TFSA for generating income. Reinvest and withdraw your funds effortlessly without tax concerns.

Read more »

Business doodle about dividends on chalkboard
Dividend Stocks

How Much to Invest in Enbridge for $1,000 a Year in Dividends

Given its resilient business model, predictable cash flows, consistent dividend growth, high yield, and healthy growth prospects, Enbridge would be…

Read more »

Blocks conceptualizing Canada's Tax Free Savings Account
Dividend Stocks

A Simple TFSA Strategy for $250 in Monthly Tax-Free Income

These Canadian stocks offer monthly dividend payments and have a solid history of payouts across all market conditions while offering…

Read more »